Topic

Chris Spivey is the editorial director of 

Articles

Change of roster does not change the goal line. We are all patients first.

New Beginnings

Rita Peters is editorial director of Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.

While the players may change, pharma’s patients-first focus should not.

The Next Chapter

Editor of Pharmaceutical Technology Europe

Excessive drug pricing is being scrutinized across Europe, as hefty fines are set to send out a clear message of intolerance to anti-competition conduct.

Drug Pricing Scrutiny Increases in Europe

Congress questions FDA on plans to catch up and move forward with facility inspections.

FDA Inspections Back on Track?

Vaccines define the path to putting the pandemic in the rear-view mirror.

Avoiding Delays on the Road to Normalcy

Five therapeutic candidates for the treatment of COVID-19 are identified as promising by the European Commission.

Identifying Promising COVID-19 Therapies

GSK’s position is raising concerns as it continues working towards its separation of businesses.

Divest and Conquer? GSK's Future is in Question

Bio/pharmaceutical manufacturers have made a good first step toward global vaccination through pledging doses at no- to low-profit rates. 

A “We are the World” Vaccination Effort?

As face masks start to come off, bio/pharma’s COVID-19 battle goes on.

Moving Into the Next Phase

The world of bio/pharma has been celebrating its achievements across a variety of categories in the latest rounds of awards.

From the Editor